1. Teatini A, Pelanis E, Aghayan DL, et al. (2019) The effect of intraoperative imaging on surgical navigation for laparoscopic liver resection surgery. Sci Rep, 9(1): 18687. [ DOI:10.1038/s41598-019-54915-3] [ PMID] [ ] 2. Fretland Å A, Kazaryan AM, Bjørnbeth BA, et al. (2015) Open versus laparoscopic liver resection for colorectal liver metastases (the Oslo-CoMet Study): study protocol for a randomized controlled trial. Trials, 16: 73. [ DOI:10.1186/s13063-015-0577-5] [ PMID] [ ] 3. Correa P (2013) Gastric cancer: overview. Gastroenterol Clin North Am, 42(2): 211-7. [ DOI:10.1016/j.gtc.2013.01.002] [ PMID] [ ] 4. Candy B, Jones L, Vickerstaff V, et al. (2018) Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. Cochrane Database Syst Rev, 6(6): Cd006332. [ DOI:10.1002/14651858.CD006332.pub3] [ PMID] [ ] 5. Ahmedzai SH, Nauck F, Bar-Sela G, et al. (2012) A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain. Palliat Med, 26(1): 50-60. [ DOI:10.1177/0269216311418869] [ PMID] [ ] 6. Sheng S, Zhao T, Wang X (2018) Comparison of robot-assisted surgery, laparoscopic-assisted surgery, and open surgery for the treatment of colorectal cancer: A network meta-analysis. Medicine (Baltimore), 97(34): e11817. [ DOI:10.1097/MD.0000000000011817] [ PMID] [ ] 7. Bull J, Wellman CV, Israel RJ, et al. (2015) Fixed-dose subcutaneous methylnaltrexone in patients with advanced illness and opioid-induced constipation: Results of a randomized, placebo-controlled study and open-label extension. J Palliat Med, 18(7): 593-600. [ DOI:10.1089/jpm.2014.0362] [ PMID] [ ] 8. Dupoiron D, Stachowiak A, Loewenstein O, et al. (2017) A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160/80 mg daily) vs oxycodone PR. Eur J Pain, 21(9): 1528-37. [ DOI:10.1002/ejp.1054] [ PMID] [ ] 9. Katakami N, Oda K, Tauchi K, et al. (2017) Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients With Cancer. J Clin Oncol, 35(17): 1921-8. [ DOI:10.1200/JCO.2016.70.8453] [ PMID] 10. Portenoy RK, Thomas J, Moehl Boatwright ML, et al. (2008) Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. J Pain Symptom Manage, 35(5): 458-68. [ DOI:10.1016/j.jpainsymman.2007.12.005] [ PMID] 11. Slatkin N, Thomas J, Lipman AG, et al. (2009) Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients. J Support Oncol, 7(1): 39-46. 12. Chamberlain BH, Cross K, Winston JL, et al. (2009) Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness. J Pain Symptom Manage, 38(5): 683-90. [ DOI:10.1016/j.jpainsymman.2009.02.234] [ PMID] 13. La Sala R, Foà C, Paoli G, et al. (2015) Multi-dimensional nursing form: a novel means of approaching nurse-led secondary cardiology prevention. Acta Biomed, 86(3): 174-82. 14. Coronado RA, Master H, White DK, et al. (2020) Early postoperative physical activity and function: a descriptive case series study of 53 patients after lumbar spine surgery. BMC Musculoskelet Disord, 21(1): 783. [ DOI:10.1186/s12891-020-03816-y] [ PMID] [ ] 15. Thomas J, Karver S, Cooney GA, et al. (2008) Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med, 358(22): 2332-43. [ DOI:10.1056/NEJMoa0707377] [ PMID] 16. Yin M, Li J, Wang J, et al. (2022) Observation of the effect of focused psychological intervention combined with standardized pain nursing on postoperative pain levels and depression and anxiety in patients with intestinal obstruction. Dis Markers, 2022: 2467887. [ DOI:10.1155/2022/2467887] [ PMID] [ ] 17. Poelaert J, Koopmans-Klein G, Dioh A, et al. (2015) Treatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipation. Clin Ther, 37(4): 784-92. [ DOI:10.1016/j.clinthera.2015.02.010] [ PMID] 18. Qiu J and Wang Y (2022) Effect of accelerated rehabilitation combined with enteral nutrition on gastrointestinal function recovery after hepatectomy. Support Care Cancer, 30(11): 8927-33. [ DOI:10.1007/s00520-022-07290-1] [ PMID] 19. Liu J, Zhang G, Xie X, et al. (2022) Effect of comprehensive nursing on quality of life of patients with cholecystolithiasis after laparoscopic surgery. Minerva Surg, 77(1): 84-6. [ DOI:10.23736/S2724-5691.21.08945-0] [ PMID]
|